Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2021 - 05 - 03    symbols : SNY    save search

Ligand Reports First Quarter 2021 Financial Results
Published: 2021-05-03 (Crawled : 22:00) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -4.18% H: 1.62% C: 1.41%
LGND | $69.89 1.99% 2.06% 140K twitter stocktwits trandingview |
Health Technology
| | O: 1.19% H: 0.26% C: -1.62%

financial results results report
Q1 2021: A Look at Biopharma’s Top 25 Companies by Market Cap
Published: 2021-05-03 (Crawled : 17:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.03% 140K twitter stocktwits trandingview |
Health Technology
| | O: 0.53% H: 1.05% C: 0.98%
LLY | News | $745.69 1.96% 0.04% 4K twitter stocktwits trandingview |
Health Technology
| | O: 0.12% H: 1.84% C: 1.6%
SNY | News | $47.69 1.15% 1.13% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -4.18% H: 1.62% C: 1.41%
REGN | News | $907.32 0.8% 0.74% 220K twitter stocktwits trandingview |
Health Technology
| | O: 0.46% H: 1.69% C: 1.06%
MRNA | News S | $107.89 3.28% 3.16% 2M twitter stocktwits trandingview |
Health Technology
| | O: 2.84% H: 2.77% C: 1.15%

biopharma
MoonLake Immunotherapeutics in-licenses potentially best-in-class Tri-specific Nanobody®,[6] Sonelokimab (M1095/ALX 0761) from Merck KGaA, Darmstadt, Germany, with goal of transforming treatment of inflammatory diseases driven by IL-17A and F
Published: 2021-05-03 (Crawled : 15:00) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -4.18% H: 1.62% C: 1.41%

disease treatment potential license germany
Himalaya Therapeutics Announces Appointment of Howe Li as Chief Medical Officer
Published: 2021-05-03 (Crawled : 14:15) - prnewswire.com
ABT | News | $107.59 0.49% 0.33% 3.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.39% H: 0.09% C: -0.85%
SNY | News | $47.69 1.15% 1.13% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -4.18% H: 1.62% C: 1.41%


Escient Pharmaceuticals Names Svetlana Makhni as Chief Financial Officer
Published: 2021-05-03 (Crawled : 14:00) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -4.18% H: 1.62% C: 1.41%


Clinical Catch-Up: April 26-30
Published: 2021-05-03 (Crawled : 14:00) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -4.18% H: 1.62% C: 1.41%


Denali Therapeutics Reports First Quarter 2021 Financial Results and Business Highlights
Published: 2021-05-03 (Crawled : 13:00) - globenewswire.com
SNY | News | $47.69 1.15% 1.13% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -4.18% H: 1.62% C: 1.41%
DNLI | $16.11 0.75% 0.74% 800K twitter stocktwits trandingview |
Health Technology
| | O: -0.36% H: 1.3% C: -3.17%

financial results results
Kymera Therapeutics Presents Positive Late-Breaking Data from Non-Interventional Study in Patients with Hidradenitis Suppurativa at the Society for Investigative Dermatology 2021 Annual Meeting
Published: 2021-05-03 (Crawled : 13:00) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -4.18% H: 1.62% C: 1.41%
KYMR | $35.71 3.96% 3.78% 440K twitter stocktwits trandingview |
Health Technology
| | O: 0.53% H: 0.0% C: -4.46%

positive
AVROBIO Provides Regulatory Update on Investigational AVR-RD-01 for Fabry Disease
Published: 2021-05-03 (Crawled : 12:00) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -4.18% H: 1.62% C: 1.41%
AVRO | $1.21 0.83% 0.41% 54K twitter stocktwits trandingview |
Health Technology
| | O: -1.71% H: 0.17% C: -17.42%

disease rd-05
Alnylam Announces Positive Early Results on Clinical Outcome Measures from ILLUMINATE-A Phase 3 Study of OXLUMO® (lumasiran)
Published: 2021-05-03 (Crawled : 12:00) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -4.18% H: 1.62% C: 1.41%
ALNY | $146.07 0.19% 0.18% 540K twitter stocktwits trandingview |
Health Technology
| | O: -0.11% H: 0.09% C: -3.66%

positive results phase 3
Relay Therapeutics Expands Clinical Leadership Team with Addition of Tara O’Meara and Charles Ferté
Published: 2021-05-03 (Crawled : 11:00) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -4.18% H: 1.62% C: 1.41%
RLAY | $5.9 -0.84% -1.02% 800K twitter stocktwits trandingview |
Health Technology
| | O: 1.45% H: 0.16% C: -1.4%


Gainers vs Losers
76% 24%

Top 10 Gainers
AGBA | $2.97 137.6% 54.87% 66M twitter stocktwits trandingview |
Finance

HKIT | $1.33 30.39% 27.14% 39K twitter stocktwits trandingview |
Technology Services

VRT 4 | $79.17 4.08% 19.36% 6.6M twitter stocktwits trandingview |
Electronic Technology

FOA 4 | $0.5144 -8.16% 15.43% 20 twitter stocktwits trandingview |
Finance and Insurance

EAST | $1.0835 16.17% 15.21% 100 twitter stocktwits trandingview |
Commercial Services

BOF | $1.17 6.36% 14.73% 15K twitter stocktwits trandingview |

LUCY | $0.2545 9.93% 13.94% 66K twitter stocktwits trandingview |
n/a

MARA | $19.44 10.77% 10.28% 630K twitter stocktwits trandingview |
Commercial Services

TSLA | News | $144.68 1.85% 9.01% 93M twitter stocktwits trandingview |
Consumer Durables

BNED | $0.2064 2.64% 8.96% 1.4M twitter stocktwits trandingview |
Retail Trade


Your saved searches
Save your searches and get alerts when important news are released.